Remission of myasthenia gravis caused by proteinuria in nephrotic syndrome

Malaz Almsaddi, Tulio Bertorini, William Bastnagel

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production. We report a 43-year-old myasthenic female who was symptomatic until she developed proteinuria from nephrotic syndrome, which caused a marked drop in acetylcholine receptor antibody titer with remission of myasthenia. Treatment of the nephrotic syndrome produced exacerbation of her myasthenia and a rise in antibody level. This patient's improvement is the result of antibody elimination during proteinuria in nephrotic syndrome.

Original languageEnglish (US)
Pages (from-to)1583-1586
Number of pages4
JournalMuscle and Nerve
Volume20
Issue number12
DOIs
StatePublished - Dec 12 1997

Fingerprint

Myasthenia Gravis
Nephrotic Syndrome
Proteinuria
Antibodies
Cholinergic Receptors
Muscle Weakness
Antibody Formation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Remission of myasthenia gravis caused by proteinuria in nephrotic syndrome. / Almsaddi, Malaz; Bertorini, Tulio; Bastnagel, William.

In: Muscle and Nerve, Vol. 20, No. 12, 12.12.1997, p. 1583-1586.

Research output: Contribution to journalArticle

Almsaddi, Malaz ; Bertorini, Tulio ; Bastnagel, William. / Remission of myasthenia gravis caused by proteinuria in nephrotic syndrome. In: Muscle and Nerve. 1997 ; Vol. 20, No. 12. pp. 1583-1586.
@article{79244bde45b441cdbd6fc1c5c56529a1,
title = "Remission of myasthenia gravis caused by proteinuria in nephrotic syndrome",
abstract = "Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production. We report a 43-year-old myasthenic female who was symptomatic until she developed proteinuria from nephrotic syndrome, which caused a marked drop in acetylcholine receptor antibody titer with remission of myasthenia. Treatment of the nephrotic syndrome produced exacerbation of her myasthenia and a rise in antibody level. This patient's improvement is the result of antibody elimination during proteinuria in nephrotic syndrome.",
author = "Malaz Almsaddi and Tulio Bertorini and William Bastnagel",
year = "1997",
month = "12",
day = "12",
doi = "10.1002/(SICI)1097-4598(199712)20:12<1583::AID-MUS14>3.0.CO;2-1",
language = "English (US)",
volume = "20",
pages = "1583--1586",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Remission of myasthenia gravis caused by proteinuria in nephrotic syndrome

AU - Almsaddi, Malaz

AU - Bertorini, Tulio

AU - Bastnagel, William

PY - 1997/12/12

Y1 - 1997/12/12

N2 - Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production. We report a 43-year-old myasthenic female who was symptomatic until she developed proteinuria from nephrotic syndrome, which caused a marked drop in acetylcholine receptor antibody titer with remission of myasthenia. Treatment of the nephrotic syndrome produced exacerbation of her myasthenia and a rise in antibody level. This patient's improvement is the result of antibody elimination during proteinuria in nephrotic syndrome.

AB - Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production. We report a 43-year-old myasthenic female who was symptomatic until she developed proteinuria from nephrotic syndrome, which caused a marked drop in acetylcholine receptor antibody titer with remission of myasthenia. Treatment of the nephrotic syndrome produced exacerbation of her myasthenia and a rise in antibody level. This patient's improvement is the result of antibody elimination during proteinuria in nephrotic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0030785315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030785315&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4598(199712)20:12<1583::AID-MUS14>3.0.CO;2-1

DO - 10.1002/(SICI)1097-4598(199712)20:12<1583::AID-MUS14>3.0.CO;2-1

M3 - Article

VL - 20

SP - 1583

EP - 1586

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 12

ER -